UTI Medium Term Fund
Direct Plan · Discontinued Flexi IDCW · UTI Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +0.44% | -0.27% | 11 of 13 |
| 1M | +1.69% | -0.28% | 11 of 13 |
| 3M | +2.41% | +0.28% | 9 of 13 |
| 6M | +2.79% | +2.23% | 9 of 13 |
| YTD | +2.76% | +2.40% | 9 of 13 |
| 1Y | +5.17% | +3.64% | 9 of 13 |
| 2Y | +7.23% | +4.97% | 9 of 13 |
| 3Y | +7.14% | +5.42% | 9 of 13 |
| 5Y | +6.17% | +4.84% | 8 of 12 |
| 7Y | +5.08% | +4.96% | 7 of 11 |
| 10Y | +4.24% | +4.63% | 8 of 11 |
| INCEPTION | +4.29% | — | — |
Ranked among: Debt Scheme - Medium Duration Fund.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +1.06% | +5.02% | -5.07% | 82% | 33% |
| 6M | +2.07% | +7.74% | -3.99% | 76% | 31% |
| 1Y | +4.05% | +10.30% | -3.15% | 91% | 37% |
| 2Y | +3.84% | +8.47% | -1.17% | 100% | 41% |
| 3Y | +3.61% | +8.10% | -0.24% | 100% | 41% |
| 5Y | +3.40% | +6.17% | +1.48% | 100% | 41% |
| 7Y | +3.43% | +5.08% | +2.23% | 100% | 41% |
| 10Y | +4.04% | +4.25% | +3.70% | 100% | 42% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity0.00%
- Debt85.31%
- Cash14.69%
- Other0.00%
Market Cap Split
- Large Cap0.00%
- Mid Cap0.00%
- Small Cap0.00%
- Others100.00%
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| 718GS2033 | SOV | 19.20% | +0.93% |
| NET CURRENT ASSETS | Net Current Assets | 14.60% | — |
| 726GOI2032 | SOV | 11.88% | +0.59% |
| SDL UP 7.79% 2033 | SOV | 9.01% | +0.47% |
| NCD BAJAJ FINANCE LTD. | Debt | 8.56% | +0.50% |
| 71GOI2034 | SOV | 7.34% | +0.36% |
| NCD ADANI POWER LTD. | Debt | 5.86% | +0.39% |
| SST-7.73%-28-9-29-PTC | Debt | 5.62% | +0.27% |
| NCD 360 ONE PRIME LTD | Debt | 4.43% | +0.29% |
| NCD ERIS LIFESCIENCES LTD | Debt | 2.95% | +0.19% |
| NCD ERIS LIFESCIENCES LTD | Debt | 2.95% | +0.19% |
| NCD ADITYA BIRLA RENEWABLES LTD | Debt | 2.94% | +0.18% |
| NCD PIRAMAL FINANCE LIMITED | Debt | 2.60% | +0.08% |
| NCD AVANSE FINANCIAL SERVICES LIMITED | Debt | 1.48% | +0.10% |
| CORPORATE DEBT MARKET DEVT FUND - A2 UNITS | - | 0.50% | +0.04% |
View all 16 holdings
| CLEARING CORPORATION OF INDIA LTD. STD - MARGIN | Net Current Assets | 0.09% | — |
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Aditya Birla Sun Life Medium Term Fund
Regular Plan · GROWTH
|
+7.86% | +9.66% | +11.81% | +8.79% |
|
Kotak Medium Term Fund
Direct Plan · Growth
|
+6.61% | +8.85% | +7.34% | +8.40% |
|
ICICI Prudential Medium Term Fund
Regular Plan · Growth
|
+6.24% | +7.64% | +6.63% | +7.60% |
|
SBI MEDIUM TERM FUND
Regular Plan · Growth
|
+5.76% | +7.09% | +6.18% | +7.56% |
|
Axis Medium Term Fund
Regular Plan · Growth Option
|
+5.64% | +7.54% | +6.55% | +7.87% |
|
HDFC Medium Term Fund
Regular Plan · Growth Option
|
+5.61% | +7.05% | +5.99% | +7.91% |
|
Nippon India Medium Term Fund (Existing Number of Segregated Portfolios - 1)
Regular Plan · Growth Option
|
+5.23% | +7.67% | +6.19% | +4.33% |
|
HSBC Medium Term Fund
Direct Plan · Growth
|
+5.17% | +7.59% | — | +7.63% |
|
Bandhan Medium Term Fund
Regular Plan · Monthly IDCW
|
-0.03% | -0.05% | +0.00% | +0.11% |
|
DSP Medium Term Fund
Regular Plan · IDCW
|
-1.19% | -0.15% | +0.13% | +0.24% |
More From UTI Asset Mgmt. Co. Ltd.
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
UTI Silver Exchange Traded Fund
Direct Plan · Growth
|
+60.20% | +44.73% | — | +35.61% |
|
UTI Silver ETF Fund of Fund
Direct Plan · Growth
|
+55.42% | +43.85% | — | +32.89% |
|
UTI - Gold Exchange Traded Fund
Direct Plan · Growth
|
+29.67% | +35.77% | +25.36% | -9.95% |
|
UTI Gold ETF Fund of Fund
Direct Plan · Growth
|
+28.83% | +34.99% | — | +30.52% |
|
UTI - Healthcare Fund
Direct Plan · IDCW
|
+19.98% | +24.09% | +16.15% | +16.46% |
|
UTI Nifty 500 Value 50 Index Fund
Direct Plan · Growth
|
+9.07% | +20.14% | — | +25.50% |
|
UTI Small Cap Fund
Direct Plan · IDCW
|
+6.76% | +13.50% | +14.94% | +20.47% |
|
UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund
Direct Plan · Growth
|
+6.69% | — | — | +10.86% |
|
UTI Ultra Short Term Fund
Direct Plan · Annual IDCW
|
+6.66% | +7.31% | +6.22% | +3.94% |
|
UTI - Arbitrage Fund
Direct Plan · Growth
|
+6.55% | +7.36% | +6.72% | +6.76% |
About This Scheme
Investment Objective
The investment objective of the scheme is to generate reasonable income by investing in debt & money market securities such that the Macaulay duration of the portfolio is between 3 to 4 years. However there can be no assurance that the investment objective of the Scheme will be achieved. The Scheme does not guarantee / indicate any returns.
Stated Asset Allocation
Debt securities (including securitized debt) : 50% - 100% Money Market Instruments (Including Triparty Repos on Government Securities or treasury bill & Repo) : 0% - 50% Asset Allocation: a. Asset allocation under normal circumstances: The Portfolio Macaulay duration would be between 3 years to 4 years b. Asset allocation in light of anticipated adverse situation: The Portfolio Macaulay duration under anticipated adverse situation is 1 year to 4years
Exit Load
Redemption / Switch out (a) within 12 months from the date of allotment – (i) upto 10% of the allotted Units - NIL (ii) beyond 10% of allotted Units - 1.00 % (b) After 12 months from the date of allotment - NIL
Fund Managers
Mr. Anurag Mittal FM 1,Not Applicable FM 2,Not Applicable FM 3,Not Applicable FM 4
Primary FM 1,Not Applicable FM 2,Not Applicable FM 3,Not Applicable FM 4
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch